ReN-002

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameReN-002
Drug Alias Namestem cell therapy (ReNeuron)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Pancreatic stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiabetes Mellitus, Type 1
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesReNeuron Group PLC
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesReNeuron Group PLC
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 1

Other Information

ATC CodeN/A
Related LinksN/A